Overview
Dr. Nada Alachkar is an associate professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include incompatible kidney transplants, kidney transplants, nephrology and pancreas transplants. Dr. Alachkar earned her M.D. at Aleppo University Faculty of Medicine in Syria. She completed residencies at Aleppo University and Wright State University School of Medicine. She performed clinical fellowship in nephrology and transplant nephrology fellowship at Johns Hopkins University. Her research interests include recurrent glomerular diseases post kidney transplantation; in particular recurrent FSGS post transplant. Also, she is studying biomarkers in kidney transplants; outcome of living and deceased donor kidney transplant recipients with positive crossmatch; and responses to desensitization treatments and post-transplant outcome in highly sensitized patients. Dr. Alachkar is a member of the American Society of Nephrology and the American Society of Transplantation.
Dr. Alachkar is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Focal Segmental Glomerulosclerosis, Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Kidney Transplant, and Splenectomy.
Her clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Diabetic Nephropathy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Oney Zuniga is a Nephrologist in Olney, Maryland. Dr. Zuniga is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Diabetic Nephropathy, Magnesium Deficiency, Gitelman Syndrome, Gastrostomy, and Endoscopy. Dr. Zuniga is currently accepting new patients.
Mid Atlantic Nephrology Associates
Jia Liu is a Nephrologist in Columbia, Maryland. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Focal Segmental Glomerulosclerosis
- Distinguished
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Alachkar isDistinguished. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
- D-Plus Hemolytic Uremic SyndromeDr. Alachkar isDistinguished. Learn about D-Plus Hemolytic Uremic Syndrome.
- End-Stage Renal Disease (ESRD)Dr. Alachkar isDistinguished. Learn about End-Stage Renal Disease (ESRD).
- GlomerulonephritisDr. Alachkar isDistinguished. Learn about Glomerulonephritis.
- Hemolytic-Uremic SyndromeDr. Alachkar isDistinguished. Learn about Hemolytic-Uremic Syndrome.
- Kidney TransplantDr. Alachkar isDistinguished. Learn about Kidney Transplant.
- Advanced
- Acute Kidney FailureDr. Alachkar isAdvanced. Learn about Acute Kidney Failure.
- Chronic Kidney DiseaseDr. Alachkar isAdvanced. Learn about Chronic Kidney Disease.
- Experienced
- Beta-Ketothiolase DeficiencyDr. Alachkar isExperienced. Learn about Beta-Ketothiolase Deficiency.
- Cytomegalic Inclusion DiseaseDr. Alachkar isExperienced. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionDr. Alachkar isExperienced. Learn about Cytomegalovirus Infection.
- Diabetic NephropathyDr. Alachkar isExperienced. Learn about Diabetic Nephropathy.
- Disseminated Intravascular CoagulationDr. Alachkar isExperienced. Learn about Disseminated Intravascular Coagulation.
- IgA NephropathyDr. Alachkar isExperienced. Learn about IgA Nephropathy.